Connect with us


Cardiac care monitor passes through health tech pilot

Avatar photo



The company behind a new ambulatory cardiac monitor has announced that it is the first technology to pass through a new digital health tech pilot.

iRhythm’s Zio XT Service has been assessed as part of the National Institute for Health and Care Excellence’s (NICE) first pilot project to evaluate digital health technologies. Zio XT has been positively recommended by NICE as an option for people with suspected cardiac arrhythmias who would benefit from ECG monitoring for longer than 24 hours.

The guidance concluded that Zio XT is convenient and easy to wear, with greater patient compliance and improved diagnostic yield (a measure of how many people with cardiac arrhythmias are diagnosed) compared with standard 24-hour Holter monitoring.

iRhythm’s technology combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with proprietary algorithms that distil data from millions of heartbeats into clinically actionable information.

Justin Hall of iRhythm said: “Throughout the COVID-19 pandemic we have seen a number of cardiac patients avoiding hospitals and suffering in silence, even when experiencing serious conditions such as strokes. This has led to a backlog of patients requiring care, putting additional pressure on medical staff and services.

“Fortunately, services like Zio can help ease this backlog, offering clinically-validated services remotely. Patients are not required to expose themselves to high-risk hospital environments, while staff can still offer the same continued level of care. It’s critical, therefore, that patients have access to these technologies and for clinicians to be able to implement them quickly and easily.”

Continue Reading
1 Comment

1 Comment

  1. Pingback: NICE commits to speed up access to health tech innovations

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending stories